Table 1 Demographic and clinicopathologic characteristics in healthy controls and patients with breast cancer.
From: FSCN1 gene polymorphisms: biomarkers for the development and progression of breast cancer
Variable | Controls N = 222 (%) | Patients N = 316 (%) | p value |
|---|---|---|---|
Age (years) | Mean ± S.D. | Mean ± S.D. | |
41.50 ± 14.96 | 53.09 ± 11.33 | p < 0.05 | |
Cigarette smoking | |||
No | 217 (97.7) | 315 (99.7) | |
Yes | 5 (2.3) | 1 (0.3) | p < 0.05 |
Alcohol consumption | |||
No | 209 (94.1) | 297 (94.0) | |
Yes | 13 (5.9) | 19 (6.0) | p > 0.05 |
Clinical stage | |||
I/II | 243 (76.9) | ||
III/IV | 73 (23.1) | ||
Tumor size | |||
≤T2 | 300 (94.9) | ||
>T2 | 16 (5.1) | ||
Lymph node status | |||
N0 + N1 | 248 (78.5) | ||
N2 + N3 | 68 (21.5) | ||
Distant metastasis | |||
M0 | 306 (96.8) | ||
M1 | 10 (3.2) | ||
Histological grade | |||
G1 + G2 | 219 (69.3) | ||
G3 | 97 (30.7) | ||
ER status | |||
Positive | 96 (30.4) | ||
Negative | 220 (69.6) | ||
PR status | |||
Positive | 146 (46.2) | ||
Negative | 170 (53.8) | ||
HER2 | |||
Positive | 199 (63.0) | ||
Negative | 117 (37.0) | ||
